OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
Journal of Virology (2025)
Open Access | Times Cited: 1
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
Journal of Virology (2025)
Open Access | Times Cited: 1
Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025
Robert Flisiak, Jerzy Jaroszewicz, Dorota Kozielewicz, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2305-2305
Open Access
Robert Flisiak, Jerzy Jaroszewicz, Dorota Kozielewicz, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2305-2305
Open Access
Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir
Kalpana Gupta, William J. O’Brien, Judith Strymish, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 3, pp. 43-43
Open Access
Kalpana Gupta, William J. O’Brien, Judith Strymish, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 3, pp. 43-43
Open Access
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Coronavirus Disease 2019 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: A Prospective Cohort Study
Jacqueline K. Kueper, Kalyani Kottilil, Giorgio Quer, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Jacqueline K. Kueper, Kalyani Kottilil, Giorgio Quer, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20–24, 2024, organized by the International Society for Antiviral Research
Stephen R. Welch, John P. Bilello, Kara Carter, et al.
Antiviral Research (2024) Vol. 232, pp. 106037-106037
Closed Access
Stephen R. Welch, John P. Bilello, Kara Carter, et al.
Antiviral Research (2024) Vol. 232, pp. 106037-106037
Closed Access
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2
Shadisadat Esmaeili, Katherine Owens, Joseph F. Standing, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Shadisadat Esmaeili, Katherine Owens, Joseph F. Standing, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A theory for viral rebound after antiviral treatment: A study case for SARS-CoV-2
Mara Pérez, Marcelo Actis, Ignacio José García Sánchez, et al.
Mathematical Biosciences (2024), pp. 109339-109339
Closed Access
Mara Pérez, Marcelo Actis, Ignacio José García Sánchez, et al.
Mathematical Biosciences (2024), pp. 109339-109339
Closed Access
